During the past 12 months, Oxford Nanopore Technologies's average Book Value Per Share Growth Rate was -14.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 47.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 48.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Oxford Nanopore Technologies was 82.60% per year. The lowest was 47.40% per year. And the median was 68.20% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Oxford Nanopore Technologies Book Value per Share Chart
Competitive Comparison of Oxford Nanopore Technologies's Book Value per Share
For the Biotechnology subindustry, Oxford Nanopore Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's PB Ratio falls into.
Oxford Nanopore Technologies Book Value per Share Calculation
Oxford Nanopore Technologies's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Oxford Nanopore Technologies (STU:4R0) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Oxford Nanopore Technologies Book Value per Share Related Terms
Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:4R0 has been successfully added to your 